Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression
Open Access
- 1 June 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (24), 25527-25534
- https://doi.org/10.1074/jbc.m401725200
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Antifolate Resistance Associated with Loss of MRP1 Expression and Function in Chinese Hamster Ovary Cells with Markedly Impaired Export of Folate and CholateMolecular Pharmacology, 2003
- Alterations in the Expression of Transcription Factors and the Reduced Folate Carrier as a Novel Mechanism of Antifolate Resistance in Human Leukemia CellsPublished by Elsevier BV ,2003
- Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia CellsPublished by Elsevier BV ,2003
- Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell linesBiochemical Journal, 2002
- Mammalian ABC Transporters in Health and DiseaseAnnual Review of Biochemistry, 2002
- Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer CellsJournal of Biological Chemistry, 2001
- Expression of Multidrug Resistance‐related Transporters in Human Breast CarcinomaJapanese Journal of Cancer Research, 2001
- Folate ReceptorsAnnual Review of Nutrition, 1996
- Anion exchange mechanism for transport of methotrexate in L1210 cellsBiochemical and Biophysical Research Communications, 1981
- THE CHARACTERISTICS OF THE MEMBRANE TRANSPORT OF AMETHOPTERIN AND THE NATURALLY OCCURRING FOLATESAnnals of the New York Academy of Sciences, 1971